Reports for APOTEX INC
Company Name
APOTEX INC
Totals |
||
Shortage reports |
3038 |
|
Actual shortage: | 231 (8%) | |
Anticipated shortage: | 14 (0%) | |
Avoided shortage: | 9 (0%) | |
Resolved: | 2784 (92%) | |
Discontinuation Reports |
356 |
|
To be discontinued: | 22 (6%) | |
Discontinued: | 334 (94%) | |
Reversed: | 0 (0%) | |
Late reports |
142 (4%) |
|
Overdue reports |
31 (12%) |
Shortage reports
Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
---|---|---|---|---|---|---|
APO-NAPROXEN | 500MG | TABLET | Resolved | 2024-02-09 | 2024-04-26 | 219171 |
APO-FOSINOPRIL | 10MG | TABLET | Resolved | 2024-02-09 | 2024-02-16 | 219168 |
APO-NAPROXEN EC TABLETS | 250MG | TABLET (ENTERIC-COATED) | Resolved | 2024-02-09 | 2024-03-29 | 219165 |
APO-MIDODRINE | 2.5MG | TABLET | Actual shortage | 2024-02-09 | 2024-03-22 | 219162 |
APO-OXCARBAZEPINE | 150MG | TABLET | Resolved | 2024-02-09 | 2024-05-10 | 219159 |
APO-LEVOFLOXACIN | 250MG | TABLET | Resolved | 2024-02-09 | 2024-03-08 | 219156 |
APO-DABIGATRAN | 110MG | CAPSULE | Resolved | 2024-02-09 | 2024-02-23 | 219152 |
APO-DABIGATRAN | 150MG | CAPSULE | Resolved | 2024-02-09 | 2024-02-23 | 219149 |
APO-ESCITALOPRAM | 20MG | TABLET | Resolved | 2024-02-09 | 2024-03-01 | 219144 |
APO-DEFERASIROX (TYPE J) | 360MG | TABLET | Resolved | 2024-02-09 | 2024-03-08 | 219141 |
APO-TRAZODONE TABLETS 100MG | 100MG | TABLET | Resolved | 2024-02-09 | 2024-03-01 | 219122 |
APO-DOXYCYCLINE MR | 40MG | CAPSULE (IMMEDIATE AND DELAYED RELEASE) | Resolved | 2024-02-02 | 2024-03-15 | 218403 |
APO-PRAVASTATIN | 10MG | TABLET | Resolved | 2024-02-02 | 2024-04-05 | 218400 |
APO-PRAVASTATIN | 40MG | TABLET | Resolved | 2024-02-02 | 2024-04-12 | 218397 |
APO-VERAP TAB 80MG | 80MG | TABLET | Resolved | 2024-02-02 | 2024-04-19 | 218394 |
ZAMINE 21 | 0.03MG 3MG | TABLET | Resolved | 2024-02-02 | 2024-03-29 | 218391 |
APO-RAMIPRIL | 1.25MG | CAPSULE | Resolved | 2024-02-02 | 2024-03-01 | 218388 |
APO-PERINDOPRIL | 4MG | TABLET | Resolved | 2024-02-02 | 2024-03-08 | 218385 |
APO-CINACALCET | 60MG | TABLET | Resolved | 2024-02-02 | 2024-03-22 | 218382 |
APO-MELOXICAM | 1.5G | SUSPENSION | Actual shortage | 2024-02-02 | 2024-05-17 | 218379 |
Discontinuation reports
Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
---|---|---|---|---|---|---|
APO-TELMISARTAN | 40MG | TABLET | Discontinued | 2019-01-04 | 2019-01-04 | 71345 |
APO-BOSENTAN | 125.0MG | TABLET | Discontinued | 2019-01-04 | 2019-01-04 | 71342 |
APO-BOSENTAN | 62.5MG | TABLET | Discontinued | 2019-01-04 | 2019-01-04 | 71339 |
APO-RIZATRIPTAN RPD | Discontinued | 2019-01-04 | 2019-04-04 | 71334 | ||
APO-IRBESARTAN | 300MG | TABLET | Discontinued | 2019-01-04 | 2019-01-04 | 71237 |
APO-IRBESARTAN | 150MG | TABLET | Discontinued | 2019-01-04 | 2019-01-04 | 71234 |
APO-IRBESARTAN | 75MG | TABLET | Discontinued | 2019-01-04 | 2019-01-04 | 71231 |
NAPROXEN SODIUM TABLETS | 220MG | TABLET | Discontinued | 2019-01-04 | 2019-01-04 | 71228 |
ACETAMINOPHEN CAPLETS 500 MG | 500MG | TABLET | Discontinued | 2019-01-04 | 2019-01-04 | 71225 |
ACETAMINOPHEN CAPLETS 325 MG | 325MG | TABLET | Discontinued | 2019-01-04 | 2019-01-04 | 71222 |
ACETAMINOPHEN TABLETS USP 325 MG | 325MG | TABLET | Discontinued | 2019-01-04 | 2019-01-04 | 71219 |
ACETAMINOPHEN TABLETS USP 500 MG | 500MG | TABLET | Discontinued | 2019-01-04 | 2019-01-04 | 71216 |
APO-LOSARTAN | 100MG | TABLET | Discontinued | 2019-01-04 | 2019-01-04 | 71213 |
ACID REDUCER | 150MG | TABLET | Discontinued | 2019-01-04 | 2019-01-04 | 71210 |
APO-METFORMIN ER | 500MG | TABLET (EXTENDED-RELEASE) | Discontinued | 2019-01-04 | 2019-01-04 | 71207 |
APO-RABEPRAZOLE | 10MG | TABLET (ENTERIC-COATED) | Discontinued | 2019-01-04 | 2019-01-04 | 71204 |
APO-RABEPRAZOLE | 20MG | TABLET (ENTERIC-COATED) | Discontinued | 2019-01-04 | 2019-01-04 | 71201 |
ACID CONTROL | Discontinued | 2019-01-04 | 2019-01-04 | 71198 | ||
APO-CEFPROZIL | 250MG | TABLET | Discontinued | 2019-01-04 | 2019-02-21 | 71195 |
ACETAMINOPHEN HEADACHE ULTRA RELIEF | 500MG 65MG | TABLET | Discontinued | 2019-01-04 | 2019-01-04 | 71192 |